Business
Oxford and AstraZeneca resume UK coronavirus vaccine trial – ABC News
Regulators give researchers the green light to continue a study that was suspended when a patient in the UK reportedly suffered a side-effect.
Oxford University has announced it will resume a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca after getting the green light from safety watchdogs.
Key points:
- Globally some 18,000 people have received the trial vaccine
- The vaccine was in late-stage clinical trials in the US, Britain, Brazil and South Africa
- The US was aiming for fast-track approval of a vaccine before November’s presidential election
The late-stage …
Continue Reading
-
Business17 hours agoWarning! These ASX 200 shares were just downgraded
-
Business14 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
Noosa News10 hours agoVegetables and herbs you can easily and cheaply grow from seeds
-
Noosa News9 hours agoNSW Diners Named Among Australia’s Stingiest Tippers